What are the key projects that you have been involved in over the past twelve months?

Over the past twelve months, I have led the legal workstream supporting Unity Care’s growth as a consolidation platform in Poland’s outpatient healthcare sector. I worked closely with business on strategic projects such as bank financing and group structuring, and I supported day-to-day commercial contracting, including negotiating and advising on agreements, as well as corporate governance matters across the group. I also coordinated as well as personally led multiple M&A transactions and drove post-merger integration, including standardising documentation across newly acquired entities.

Have you had any experiences during your career as a lawyer that stand out as particularly unique or interesting?

During my earlier role as Legal and Compliance Director at Scanmed Group, which was part of Life Healthcare Group, an international healthcare provider listed on the Johannesburg Stock Exchange, I had a chance to gain international experience across compliance, risk and corporate governance. It was a great opportunity to implement group’s best standards and translate them into local policies and processes.

At that time, I gained exposure to working in an international environment, with a dotted-line reporting relationship to the Group Legal and Compliance Director, and increasing collaboration with C-level executives and colleagues across different countries. Particularly valuable were my experiences from business continuity projects during the COVID-19 pandemic, which required close coordination and staying up to date with new legal and regulatory requirements emerging at pace in the healthcare sector.

A particularly interesting chapter followed when Life Healthcare sold Scanmed at the end of 2020 to Abris, a CEE-focused private equity investor. This gave me first-hand exposure to operating as a PE portfolio company and supporting a value-creation agenda, including ESG transformation initiatives. Working with a private equity investor brought a higher-intensity environment, a faster pace of execution, and more structured

expectations around corporate governance, reporting and performance management, which significantly broadened my perspective and experience.

What is more, I was directly involved in the legal workstream of Abris’s exit from Scanmed, completed in December 2024, which became the largest medical transaction in Poland in recent years. Overall, these experiences were unique because they allowed me to see the business both through the lens of a strategic investor and a financial investor.

What do you think are the most important attributes for a modern in-house counsel to possess?

I believe that the most important attribute of a modern in-house counsel is strong business and sector understanding, because it enables you to be a genuine partner and to grasp the purpose behind regulations. It also helps anticipate issues early and shape solutions that fit the realities of the sector and the organisation.

Equally important is clear, practical communication: translating legal and industry insight into guidance that does not hide behind jargon, explains risks plainly and points to the most effective legal options. This is what builds trust with stakeholders and makes legal advice truly useful.

Finally, sound judgement is key: being able to prioritise issues, calibrate risk and propose solutions that are proportionate to the business need. In practice, that means focusing on what truly matters, avoiding unnecessary complexity, and helping the business move forward with confidence.